Gene · 8202
Papers3,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring new pathways in endocrine-resistant breast cancer. | Explor Target Antitumor Ther | 2022 | 36045911 | PubTator, text mining | PubMed |
| Identification and Validation of Three Hub Genes Involved in Cell Proliferation and Prognosis of Castration-Resistant Prostate Cancer. | Oxid Med Cell Longev | 2022 | 36035209 | PubTator, text mining | PubMed |
| Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing. | Front Oncol | 2022 | 36033527 | PubTator, text mining | PubMed |
| Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing. | Vaccines (Basel) | 2022 | 36016137 | PubTator, text mining | PubMed |
| Application of CRISPR-Cas9 Gene Editing for HIV Host Factor Discovery and Validation. | Pathogens | 2022 | 36015010 | PubTator, text mining | PubMed |
| Role of the WNT/β-catenin/ZKSCAN3 Pathway in Regulating Chromosomal Instability in Colon Cancer Cell lines and Tissues. | Int J Mol Sci | 2022 | 36012568 | PubTator, text mining | PubMed |
| Targeting Histone Epigenetic Modifications and DNA Damage Responses in Synthetic Lethality Strategies in Cancer? | Cancers (Basel) | 2022 | 36011043 | PubTator, text mining | PubMed |
| Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease. | Biomedicines | 2022 | 36009418 | PubTator, text mining | PubMed |
| Tumor-Promoting ATAD2 and Its Preclinical Challenges. | Biomolecules | 2022 | 36008934 | PubTator, text mining | PubMed |
| Exploring the Novel Computational Drug Target and Associated Key Pathways of Oral Cancer. | Curr Issues Mol Biol | 2022 | 36005140 | PubTator, text mining | PubMed |
| Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence. | Genome Biol | 2022 | 35996163 | PubTator, text mining | PubMed |
| Target expression is a relevant factor in synthetic lethal screens. | Commun Biol | 2022 | 35986164 | PubTator, text mining | PubMed |
| RB1 loss triggers dependence on ESRRG in retinoblastoma. | Sci Adv | 2022 | 35984874 | PubTator, text mining | PubMed |
| Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity. | PLoS One | 2022 | 35976950 | PubTator, text mining | PubMed |
| Modulating biomolecular condensates: a novel approach to drug discovery. | Nat Rev Drug Discov | 2022 | 35974095 | PubTator, text mining | PubMed |
| Androgen receptor signaling and spatial chromatin organization in castration-resistant prostate cancer. | Front Med (Lausanne) | 2022 | 35966880 | PubTator, text mining | PubMed |
| Transcriptional regulation by a RecQ helicase. | Methods Enzymol | 2022 | 35965009 | PubTator, text mining | PubMed |
| Targeting purine metabolism in ovarian cancer. | J Ovarian Res | 2022 | 35964092 | PubTator, text mining | PubMed |
| A review of osteoarthritis signaling intervention using small-molecule inhibitors. | Medicine (Baltimore) | 2022 | 35960127 | PubTator, text mining | PubMed |
| Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy. | Int J Mol Sci | 2022 | 35955731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8202/papers?page=23